TY - JOUR
T1 - European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer
AU - Oonk, Maaike H M
AU - Planchamp, François
AU - Baldwin, Peter
AU - Bidzinski, Mariusz
AU - Brännström, Mats
AU - Landoni, Fabio
AU - Mahner, Sven
AU - Mahantshetty, Umesh
AU - Mirza, Mansoor
AU - Petersen, Cordula
AU - Querleu, Denis
AU - Regauer, Sigrid
AU - Rob, Lukas
AU - Rouzier, Roman
AU - Ulrikh, Elena
AU - van der Velden, Jacobus
AU - Vergote, Ignace
AU - Woelber, Linn
AU - van der Zee, Ate G J
PY - 2017/5
Y1 - 2017/5
N2 - OBJECTIVE: The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe.METHODS: The European Society of Gynaecological Oncology Council nominated an international development group made of practicing clinicians who provide care to patients with vulvar cancer and have demonstrated leadership and interest in the management of patients with vulvar cancer (18 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 181 international reviewers including patient representatives independent from the development group.RESULTS: The guidelines cover diagnosis and referral, preoperative investigations, surgical management (local treatment, groin treatment including sentinel lymph node procedure, reconstructive surgery), radiation therapy, chemoradiation, systemic treatment, treatment of recurrent disease (vulvar recurrence, groin recurrence, distant metastases), and follow-up.
AB - OBJECTIVE: The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe.METHODS: The European Society of Gynaecological Oncology Council nominated an international development group made of practicing clinicians who provide care to patients with vulvar cancer and have demonstrated leadership and interest in the management of patients with vulvar cancer (18 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Prior to publication, the guidelines were reviewed by 181 international reviewers including patient representatives independent from the development group.RESULTS: The guidelines cover diagnosis and referral, preoperative investigations, surgical management (local treatment, groin treatment including sentinel lymph node procedure, reconstructive surgery), radiation therapy, chemoradiation, systemic treatment, treatment of recurrent disease (vulvar recurrence, groin recurrence, distant metastases), and follow-up.
KW - Female
KW - Gynecology
KW - Humans
KW - Journal Article
KW - Medical Oncology
KW - Practice Guideline
KW - Practice Guidelines as Topic
KW - Vulvar Neoplasms
U2 - https://doi.org/10.1097/IGC.0000000000000975
DO - https://doi.org/10.1097/IGC.0000000000000975
M3 - Article
C2 - 28441255
SN - 1048-891X
VL - 27
SP - 832
EP - 837
JO - International journal of gynecological cancer
JF - International journal of gynecological cancer
IS - 4
ER -